Antitope Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The companys iTope technology is used to identify peptides; and T Cell Epitope Database is used for screening amino acid sequences from antibodies or proteins. Its EpiScreen T cell epitope mapping identifies the exact number and location of T cell epitopes within an antibody or protein. Antitopes technologies are used in the immunogenicity assessment and protein engineering to develop humanized antibodies and deimmunised proteins. The company also provides services and technologies for the selection, development and manufacturing of biopharmaceuticals based on antibodies and other proteins. Antitope is headquartered in Cambridge, the UK.
Antitope Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The companys iTope technology is used to identify peptides; and T Cell Epitope Database is used for screening amino acid sequences from antibodies or proteins. Its EpiScreen T cell epitope mapping identifies the exact number and location of T cell epitopes within an antibody or protein. Antitopes technologies are used in the immunogenicity assessment and protein engineering to develop humanized antibodies and deimmunised proteins. The company also provides services and technologies for the selection, development and manufacturing of biopharmaceuticals based on antibodies and other proteins. Antitope is headquartered in Cambridge, the UK.
Antitope Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Antitope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Antitope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Antitope Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 10
Antitope Enters Into Research Agreement With Annexon For Therapeutic Antibodies 11
Antitope Enters Into Research Agreement With ChemomAb For Composite Human Antibodies 12
Antitope Enters Into Co-Development Agreement With Research Corporation Technologies For Therapeutic Protein 12
Antitope Enters Into Co-Development Agreement With Eden Biodesign For Therapeutic Antibodies 13
Antitope Enters Into Research Agreement With NeuroPhage Pharma 14
Antitope Enters Into Research Collaboration With Therapure Biopharma 14
Antitope Enters Into Co-Development Agreement With Kolltan Pharma 15
Antitope Enters Into Co-Development Agreement With The University Of North Carolina 16
Antitope Enters Into Co-Development Agreement With IMMIH 17
Antitope Enters Into Research Collaboration With NasVax 18
Licensing Agreements 19
ProtAb Enters into License Agreement with Antitope 19
Antitope Enters into Licensing Agreement with University College London for Humanized Antibodies 19
Acquisition 20
PolyTherics Acquires Antitope For US$20.7 Million 20
Antitope Ltd - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Government and Public Interest 25
Jan 18, 2016: Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List Of Tables
Antitope Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Antitope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Antitope Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Antitope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 10
Antitope Enters Into Research Agreement With Annexon For Therapeutic Antibodies 11
Antitope Enters Into Research Agreement With ChemomAb For Composite Human Antibodies 12
Antitope Enters Into Co-Development Agreement With Research Corporation Technologies For Therapeutic Protein 12
Antitope Enters Into Co-Development Agreement With Eden Biodesign For Therapeutic Antibodies 13
Antitope Enters Into Research Agreement With NeuroPhage Pharma 14
Antitope Enters Into Research Collaboration With Therapure Biopharma 14
Antitope Enters Into Co-Development Agreement With Kolltan Pharma 15
Antitope Enters Into Co-Development Agreement With The University Of North Carolina 16
Antitope Enters Into Co-Development Agreement With IMMIH 17
Antitope Enters Into Research Collaboration With NasVax 18
ProtAb Enters into License Agreement with Antitope 19
Antitope Enters into Licensing Agreement with University College London for Humanized Antibodies 19
PolyTherics Acquires Antitope For US$20.7 Million 20
Antitope Ltd, Key Competitors 22
Antitope Ltd, Key Employees 23
List Of Figures
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RELATED REPORTS
TBG Diagnostics Ltd - Product Pipeline Analysis, 2021 Update
TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The companys major products include
View ReportHuntleigh Healthcare Ltd - Product Pipeline Analysis, 2021 Update
Huntleigh Healthcare Ltd (Huntleigh Healthcare) is a medical device company. The company develops, manufactures and distributes electronic medical equipment. It offers vascular assessment and treatment; fetal and patient monitoring; and
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
